For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $73.04 in the prior trading day, Solventum Corp (NYSE: SOLV) closed at $74.6, up 2.14%. In other words, the price has increased by $2.14 from its previous closing price. On the day, 0.89 million shares were traded. SOLV stock price reached its highest trading level at $74.63 during the session, while it also had its lowest trading level at $72.73.
Ratios:
Our goal is to gain a better understanding of SOLV by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 26.29 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 87.99. For the most recent quarter (mrq), Quick Ratio is recorded 0.86 and its Current Ratio is at 1.22. In the meantime, Its Debt-to-Equity ratio is 2.14 whereas as Long-Term Debt/Eq ratio is at 2.14.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, UBS on October 01, 2025, initiated with a Neutral rating and assigned the stock a target price of $77.
On September 11, 2025, Jefferies started tracking the stock assigning a Hold rating and target price of $80.
Morgan Stanley Upgraded its Equal-Weight to Overweight on July 15, 2025, while the target price for the stock was maintained at $103.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 15 ’25 when 3M CO sold 8,800,000 shares for $73.45 per share. The transaction valued at 646,360,000 led to the insider holds 25,569,190 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SOLV now has a Market Capitalization of 12934728704 and an Enterprise Value of 20257730560. As of this moment, Solventum’s Price-to-Earnings (P/E) ratio for their current fiscal year is 34.36, and their Forward P/E ratio for the next fiscal year is 11.86. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 24.20. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.54 while its Price-to-Book (P/B) ratio in mrq is 3.55. Its current Enterprise Value per Revenue stands at 2.415 whereas that against EBITDA is 14.787.
Stock Price History:
The Beta on a monthly basis for SOLV is 0.64, which has changed by 0.1012696 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, SOLV has reached a high of $85.92, while it has fallen to a 52-week low of $60.70. The 50-Day Moving Average of the stock is 2.42%, while the 200-Day Moving Average is calculated to be 2.86%.
Shares Statistics:
The stock has traded on average 1.03M shares per day over the past 3-months and 1117070 shares per day over the last 10 days, according to various share statistics. A total of 173.39M shares are outstanding, with a floating share count of 147.50M. Insiders hold about 14.93% of the company’s shares, while institutions hold 67.07% stake in the company. Shares short for SOLV as of 1757894400 were 4021035 with a Short Ratio of 3.89, compared to 1755216000 on 3851305. Therefore, it implies a Short% of Shares Outstanding of 4021035 and a Short% of Float of 2.8900001.
Earnings Estimates
The company has 10.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $1.49, with high estimates of $1.54 and low estimates of $1.43.
Analysts are recommending an EPS of between $6.03 and $5.88 for the fiscal current year, implying an average EPS of $5.96. EPS for the following year is $6.31, with 12.0 analysts recommending between $6.65 and $6.1.
Revenue Estimates
10 analysts predict $2.04B in revenue for. The current quarter. It ranges from a high estimate of $2.08B to a low estimate of $1.95B. As of. The current estimate, Solventum Corp’s year-ago sales were $2.08BFor the next quarter, 10 analysts are estimating revenue of $1.96B. There is a high estimate of $1.98B for the next quarter, whereas the lowest estimate is $1.94B.
A total of 10 analysts have provided revenue estimates for SOLV’s current fiscal year. The highest revenue estimate was $8.28B, while the lowest revenue estimate was $7.77B, resulting in an average revenue estimate of $8.2B. In the same quarter a year ago, actual revenue was $8.25BBased on 10 analysts’ estimates, the company’s revenue will be $7.95B in the next fiscal year. The high estimate is $8.02B and the low estimate is $7.69B.
